Whole Genome MBD-seq reveals different CpG methylation patterns in Azacytidine-treated Juvenile Myelomonocytic Leukaemia (JMML) patients.
about
Whole Genome MBD-seq reveals different CpG methylation patterns in Azacytidine-treated Juvenile Myelomonocytic Leukaemia (JMML) patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Whole Genome MBD-seq reveals d ...... tic Leukaemia (JMML) patients.
@en
Whole Genome MBD-seq reveals d ...... enile Myelomonocytic Leukaemia
@nl
type
label
Whole Genome MBD-seq reveals d ...... tic Leukaemia (JMML) patients.
@en
Whole Genome MBD-seq reveals d ...... enile Myelomonocytic Leukaemia
@nl
prefLabel
Whole Genome MBD-seq reveals d ...... tic Leukaemia (JMML) patients.
@en
Whole Genome MBD-seq reveals d ...... enile Myelomonocytic Leukaemia
@nl
P2093
P2860
P356
P1476
Whole Genome MBD-seq reveals d ...... ytic Leukaemia (JMML) patients
@en
P2093
Angela Pitisci
Charlotte Niemeyer
Francesca Di Florio
Franco Locatelli
Katia Girardi
Maria Giuseppina Cefalo
Patrizia Vitullo
Valeria Tocco
P2860
P304
P356
10.1111/BJH.14876
P407
P577
2017-08-02T00:00:00Z